Alibaba Q2 2023 earnings, shelves cloud spinoff

Celebrity Gig


Signage at the Alibaba Group Holding Ltd. booth at the Smart China Expo in Chongqing, China, on Monday, Sept. 4, 2023.

Qilai Shen | Bloomberg | Getty Images

U.S.-listed shares of Chinese e-commerce giant Alibaba slid on Thursday after it announced that it would not proceed with the full spin-off of its cloud group due to U.S. chip export restrictions.

The company’s stock was down just over 8% in pre-market trading at 7.40 a.m. ET following the news, off earlier lows.

In its earnings release Thursday, Alibaba said that it would no longer proceed with a spin-off of its Cloud Intelligence Group — the cloud computing arm of Alibaba that competes with Amazon Web Services and Microsoft Azure. Alibaba had planned to list the division publicly.

Alibaba said U.S. chip export restrictions have made it harder for Chinese firms to get critical chip supplies from U.S. companies. The U.S. barred sales of Nvidia‘s advanced artificial intelligence-focused H800 and A800 chips in October.

READ ALSO:  Solar solution will create economic opportunities, says firm

On Thursday, Alibaba said that the restrictions have “created uncertainties for the prospects of Cloud Intelligence Group.”

“We believe that a full spin-off of Cloud Intelligence Group may not achieve the intended effect of shareholder value enhancement,” the company said, adding that it would instead focus on developing a sustainable growth model for the unit “under the fluid circumstances.”

The decision to walk back its cloud unit spinout marks a hitch in Alibaba’s plan to reorganize into six individual business units — one of the most radical shake-ups in the company’s history.

Alibaba had earlier announced that it would put on hold plans to list its Freshippo retail chain for groceries “as we evaluate market conditions and other factors.”

The company still intends to list its Cainiao smart logistics division in Hong Kong.

READ ALSO:  Strike will disrupt economy, says OPSN

The Thursday results mark the first set of Alibaba earnings since veteran executive Eddie Wu succeeded former boss Daniel Zhang as CEO. As part of a broader management reshuffle, the company’s co-founder Joe Tsai also took over as chairman, Alibaba said in June.

Alibaba reported net income attributable to shareholders of 27.7 billion yuan ($3.8 billion) for the September quarter, below the 29.7 billion yuan expected by analysts.

Revenue met expectations, however, coming in at 224.79 billion yuan ($31 billion), up 9% year-over-year.

First-ever dividend payout

The company also announced that it will issue its first-ever annual cash dividend in 2023. Companies use dividends to share a portion of their profit with shareholders.

In the release, Alibaba said that its board of directors had approved an annual $0.125 per ordinary share or $1 per American depositary share (ADS) cash dividend for the fiscal year.

The aggregate amount of the dividend will be roughly $2.5 billion. Alibaba will pay the sum out to investors at the close of business on Dec. 21, 2023, Hong Kong Time and New York Time, respectively.

READ ALSO:  Quordle today – hints and answers for Friday, May 3 (game #830)

“Going forward, we will continue to review and determine the dividend amount based on factors such as business fundamentals, capital requirements, among others, on an annual basis,” Alibaba said in its earnings release.

Chinese economy

Alibaba’s results are often viewed as an indication of the health of the Chinese consumer.

Economists were expecting a boom in China’s economy following its emergence from Covid-19 lockdowns last year, but the rebound has proven more tepid, with a property crisis and other structural challenges posing risks to the country’s recovery.

Alibaba said it recorded healthy year-over-year growth in users of its Taobao and Tmall domestic online shopping sites, however. The two sites saw positive year-over-year order growth during the annual 11:11 Chinese shopping holiday, Alibaba added.

Categories

Share This Article
Leave a comment